Skip to main content

Table 1 NIS mRNA levels do not vary among human breast tumors as detected by oligonucleotide microarray technology

From: Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer

Microarray Platform

NIS Probe Set ID

Probe Length

Target (NIS Sequence)

Standard Deviation

Affymetrix HG U133 Plus 2.0

211123_at

25-mer (n* = 11)

5'-1521-1991-3'

Avg. 0.23, Range 0.17-0.28 (N# = 2)

Affymetrix HG U95A

32459_at

25-mer (n* = 16)

5'-1522-1998-3'

Avg. 0.20, Range 0.14-0.26 (N# = 2)

Affymetrix Human X3P

G2887404_3p_at

25-mer (n* = 11)

5'-1693-1992-3'

Avg. 0.18, Range 0.18-0.18 (N# = 2)

Applied Biosystems Human Survey Microarray V1

193100

60-mer (n* = 1)

Proprietary

0.21 (N# = 1)

Agilent-012391 Human Genome

30047

60-mer (n* = 1)

5'-1707-1767-3'

0.13 (N# = 1)

  1. *, Number of perfect match oligonucleotide probes within the NIS probe set.
  2. #, Number of datasets examined that utilized each respective microarray platform.